Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 07, 2026
Why Is Palantir Technologies (PLTR) Stock Up +9.56% Today?

Why Is Palantir Technologies (PLTR) Stock Up +9.56% Today?

Key Takeaways

  • Palantir shares surged 9.56% to $170.82 on Thursday, building on the massive earnings-driven rally earlier this week.
  • Q2 2026 results crushed expectations: revenue soared 93% year-over-year to $1.94 billion, with U.S. commercial revenue jumping 149% and EPS of $0.41 beating consensus by nearly 17%.
  • Massive guidance raise: management lifted full-year 2026 revenue guidance to approximately $8.15 billion, implying 82% growth, and expects U.S. commercial revenue growth of at least 134%.
  • Broader software sector momentum added fuel, as strong results from peers like Twilio helped ease investor fears that AI would commoditize enterprise software.
  • Short-squeeze dynamics amplified the move, with short sellers reportedly losing billions in paper gains as the stock reversed sharply off 2026 lows.
  • Traders now watch whether PLTR can hold above the $160 level and whether upcoming Q3 results sustain the accelerating growth trajectory.

Opening Summary

PLTR, the AI-driven data analytics and software company, surged another 9.56% in Thursday's trading session to $170.82, extending an extraordinary post-earnings rally that has redefined the stock's 2026 narrative. The move follows a prior close of $155.92 on Wednesday and comes on the heels of what CEO Alex Karp described as an "otherworldly" second-quarter earnings report released after Monday's close. Palantir Technologies, headquartered in Denver, Colorado, builds operating systems for data-driven decision-making across government and commercial sectors through its Gotham, Foundry, and Artificial Intelligence Platform (AIP) software suites.

Blowout Q2 Earnings Continue to Reverberate

The primary engine behind this week's extraordinary price action is Palantir's second-quarter 2026 earnings report, which shattered Wall Street expectations and fundamentally shifted market sentiment toward the stock. Revenue climbed 93% year-over-year to $1.94 billion, surpassing the $1.81 billion consensus estimate. Adjusted earnings per share of $0.41 beat the $0.35 analyst forecast by more than 17%, marking the twelfth consecutive quarter of accelerating revenue growth.

U.S. commercial revenue, widely viewed as the most critical metric for the bear-or-bull debate, jumped 149% year-over-year to $764 million, accelerating from the 133% growth posted in the first quarter and effectively silencing the bear case that Palantir's commercial expansion was decelerating. U.S. government revenue grew 90% to $809 million, pushing total U.S. revenue up 115% to $1.57 billion. GAAP net income reached $1.06 billion — a 55% margin — while adjusted free cash flow hit $1.22 billion, representing a 63% margin. These numbers demonstrate that Palantir's hypergrowth is paired with genuine profitability, a combination rarely seen in enterprise software at this scale.

Guidance Raise Signals Sustained Momentum

If beating the quarter was the spark, the dramatically raised outlook was the accelerant. Palantir lifted full-year 2026 revenue guidance to a range of $8.15 billion to $8.158 billion, up from its prior forecast of $7.65 billion to $7.66 billion, representing approximately 82% year-over-year growth. U.S. commercial revenue is now expected to exceed $3.424 billion, implying at least 134% growth — up from the previous 120% target. Adjusted operating income guidance rose to $4.889–$4.897 billion, and the company guided for third-quarter revenue of $2.160–$2.164 billion, well above the $2 billion consensus.

The sheer magnitude of the guidance raise — the second consecutive double-digit percentage-point increase — convinced many investors that Palantir's AI-driven growth cycle remains in its early innings. Dealmaking data reinforced that conviction: the company closed 220 deals worth at least $1 million, including 73 deals of at least $10 million. U.S. commercial total contract value hit a record $2.13 billion, up 153% year-over-year.

Broader Software Rally and Shifting AI Sentiment

Thursday's additional surge was fueled in part by a broader re-rating of enterprise software stocks. Strong quarterly results from TWLO and other software companies eased persistent investor fears that advancing AI models would commoditize traditional enterprise software, including Palantir's platforms. The narrative that "AI eats software" has dogged Palantir throughout its 2026 sell-off, but the company's Q2 results and subsequent peer reports are steadily dismantling that thesis. Palantir's AIP platform, which integrates large language models into real-world enterprise data environments with governance and security controls, is increasingly seen as a beneficiary — not a victim — of AI proliferation.

Short Squeeze Amplifies the Upside

Palantir's dramatic recovery has been turbocharged by a punishing short squeeze. According to data from S3 Partners, short sellers had amassed roughly $2.7 billion in mark-to-market gains for 2026 before the earnings report. The stock's 30% surge on Tuesday alone wiped out those gains entirely and pushed aggregate short-side losses to approximately $3 billion. Forced covering by bearish investors has created a self-reinforcing upward spiral, adding mechanical buying pressure on top of fundamentally driven demand. The stock had entered the week down roughly 30% year-to-date and more than 40% below its November 2025 peak near $207, making it a crowded short that was primed for a violent reversal.

Market Context and Trading Activity

Thursday's move pushed PLTR decisively above the $160 resistance level that had capped the stock at multiple points earlier in 2026. Volume remained elevated well above average, reflecting sustained institutional and retail interest in the wake of the earnings report. The stock's relative strength index (RSI) has moved into technically overbought territory, though momentum-driven rallies in high-growth names have historically sustained such readings for extended periods. The move also aligned with positive action in AI-themed ETFs and the broader technology sector, though Palantir's gains far outpaced the major indices on the day.

What Comes Next for PLTR

Palantir's immediate challenge is consolidating its post-earnings gains and proving that the Q2 growth rate is sustainable. Third-quarter results, guided to approximately $2.16 billion in revenue, will be the next major test. Wall Street analysts have responded bullishly: UBS maintained a Buy rating and raised its price target to $220, while Bank of America reiterated Buy with a $255 target. However, valuation remains a legitimate point of debate — even after this week's rally, the stock trades at approximately 40 times guided 2026 revenue and more than 80 times forward earnings, leaving minimal room for execution missteps. Bears, including Jefferies with its Underperform rating, argue the premium is unsustainable. Investors will also monitor federal contract developments, including Palantir's recently announced partnership with Mercury Systems to digitize military supply chains, for evidence of continued government momentum.

Trending AI Robots

Tickeron's Trending AI Robots page features a curated selection of AI-driven trading bots that have demonstrated superior performance in current market conditions. With hundreds of bots covering thousands of tickers — including PLTR — each bot is differentiated by its unique strategy, trading timeframe, and performance metrics. Only the strongest performers are highlighted in the Trending AI Robots section, allowing traders to identify the strategies best aligned with today's fast-moving markets. Explore the Trending AI Robots page to see which AI-powered approaches are navigating this environment most effectively.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PLTR

Contributor

<p>Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years&nbsp;developing&nbsp;his proprietary trading and quantitative algorithms (now Tickeron&rsquo;s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional,&nbsp;sophisticated stock market analysis capabilities to retail investors via&nbsp;an easy-to-use interface.</p>


PLTR's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PLTR turned positive on August 04, 2026. Looking at past instances where PLTR's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on PLTR as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

PLTR moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PLTR crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where PLTR advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PLTR broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PLTR entered a downward trend on July 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PLTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (42.373) is normal, around the industry mean (24.242). P/E Ratio (147.017) is within average values for comparable stocks, (72.348). Projected Growth (PEG Ratio) (2.370) is also within normal values, averaging (1.893). PLTR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (71.942) is also within normal values, averaging (132.770).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), Twilio (NYSE:TWLO), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.05B. The market cap for tickers in the group ranges from 48.8K to 3.71T. MSFT holds the highest valuation in this group at 3.71T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 6%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 21%. AEVA experienced the highest price growth at 53%, while WETO experienced the biggest fall at -98%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was -47%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 73
Price Growth Rating: 57
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
PLTR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ComputerCommunications

Profile
Details
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.